The biological origin of lactose tolerance: The LCT gene

Lactose is the main carbohydrate naturally present in mammalian milk. It is a disaccharide composed of two simple sugars: glucose and galactose. In order to be absorbed in the intestine and used as an energy source by our cells, lactose must be hydrolyzed (broken down) into its two individual components in the brush border of the enterocytes in the small intestine. This crucial chemical reaction is carried out by a specialized enzyme called lactose-binding enzyme. lactase-phloricin hydrolase, encoded by the gene LCT.

In almost all mammals, the expression of the LCT gene and the consequent production of the lactase enzyme are programmed to decrease drastically and progressively after weaning. From an evolutionary perspective, this biological regulation is consistent: once the offspring stops feeding on its mother's milk, it no longer needs to expend metabolic resources producing an enzyme for a food it will no longer consume. In humans, however, an extraordinary evolutionary change occurred linked to the development of livestock farming and pastoralism around 10,000 years ago.

What is lactase and how does it work?

The enzyme lactase breaks the beta-glycosidic bond of lactose in the small intestine. When lactase levels are high, this process occurs silently and asymptomatically, and the resulting glucose and galactose enter the bloodstream normally. However, if there is a deficiency or absence of this enzyme, lactose passes through the small intestine undigested and reaches the colon directly, where it undergoes accelerated fermentation by the resident gut microbiota, triggering all the classic symptoms of lactose intolerance.

The evolution of lactase persistence in humans

The phenomenon by which some adult humans retain the ability to digest lactose indefinitely is known as lactase persistenceThis phenotypic trait is not due to direct changes in the coding sequence of the LCT gene, but to genetic mutations occurring in an adjacent regulatory region located in the gene. MCM6which acts as an enhancer of LCT gene transcription. Several independent mutations arose in parallel in populations of Central Europe, North Africa, and the Middle East, allowing our ancestors to tolerate fresh milk during times of crop scarcity, which provided a colossal selective survival advantage. In populations where livestock farming was not historically predominant, such as in East Asia or Native American populations, lactase persistence is extremely rare, and more than 90% of adults suffer from primary lactose intolerance.

Molecular diagnostics: Deciphering the variants of the LCT gene

The Oorenji genetic and precision test (https://oorenji.com) thoroughly analyzes the most representative and scientifically validated polymorphism associated with lactase persistence and non-persistence in European populations.

The C/T-13910 polymorphism and its clinical impact

This polymorphism is located in the MCM6 regulatory region and gives rise to three possible genotypes that molecularly determine digestive tolerance:

• CC Genotype (Lactase Non-Persistence): This is the risk genotype. Individuals with the CC genotype experience a genetically programmed decline in the transcription of the LCT gene and, therefore, a gradual and severe loss of lactase enzyme activity starting in childhood or adolescence. Sooner or later, these individuals will develop primary lactose intolerance, exhibiting symptoms such as bloating, abdominal pain, rumbling bowel sounds (borborygmi), and osmotic diarrhea after consuming moderate amounts of dairy products.
• CT Genotype (Partial Persistence): These individuals are heterozygous and retain intermediate lactase activity. They are generally able to tolerate moderate daily portions of lactose (such as a glass of milk, yogurt, or cheese) without experiencing limiting digestive discomfort, although they may exhibit symptoms with unusual dairy overload.
• TT Genotype (Total Persistence): Carriers of the TT genotype maintain high levels of lactase production throughout their adult life, tolerating regular intake of milk and dairy products without any primary enzymatic difficulty.

Difference between primary intolerance, secondary intolerance and allergy

It is essential that healthcare professionals and users accurately distinguish clinically three different entities that are often confused in consultations:

1. Primary lactose intolerance: Genetically determined (LCT CC genotype). It is progressive, irreversible, and permanent over time, although the individual tolerance threshold varies according to the patient's microbiota.
2. Secondary lactose intolerance: It's not determined by your genetics, but by structural damage to the lining of the small intestine that temporarily destroys the brush border where lactase resides. This can be due to untreated celiac disease, Crohn's disease, acute infectious gastroenteritis, or small intestinal bacterial overgrowth (SIBO). Once the intestinal lining is restored, lactose tolerance is fully recovered. The Oorenji test clearly distinguishes between these conditions.
3. Cow's milk protein allergy (CMPA): It is an immune reaction (classically mediated by IgE antibodies) directed against proteins such as casein or beta-lactoglobulin in milk. It has nothing to do with lactose and requires the complete and immediate elimination of any trace of dairy to avoid severe anaphylactic reactions.

Precision nutritional approach for the CC (non-persistent) genotype

Receiving a CC genotype genetic result shouldn't be cause for alarm, nor should it lead to the indiscriminate elimination of all dairy products. A precision nutrition approach guided by Oorenji teaches you how to eat intelligently to protect your bone health, gut microbiota, and digestive well-being.

Fermented dairy alternatives and threshold tolerance

Most people with the CC genotype retain the ability to tolerate up to 12 grams of lactose in a single serving (roughly equivalent to a 250 ml cup of milk) if consumed with other foods that slow gastric emptying, thus reducing the rate at which lactose reaches the colon.

In addition, there are highly recommended fermented dairy products:

• Natural yogurt and kefir: The lactic acid bacteria used in fermentation (such as Lactobacillus bulgaricus and Streptococcus thermophilusThey produce their own intracellular bacterial lactase enzyme. Upon reaching the intestine, bile breaks down the membrane of these bacteria, releasing lactase into the intestinal lumen to help digest the residual lactose in yogurt naturally.
• Cured and semi-cured cheeses (Parmesan, Manchego, Cheddar): During the cheesemaking process, most of the lactose is removed along with the whey. Subsequently, lactic bacteria consume the remaining lactose during the ripening process. As a general rule, the more aged a cheese is, the lower its lactose content will be, becoming virtually zero in cheeses aged for more than six months.

Alternative sources of calcium and vitamin D with high bioavailability

If the patient decides to significantly reduce dairy consumption, it is imperative to ensure a sufficient intake of calcium (about 1000 mg daily in adults) and vitamin D to preserve bone mineral density and prevent osteoporosis in the long term.

Plant-based foods and small fish with bones

Calcium is not exclusive to milk. Excellent, bioavailable sources include:

• Small fish with edible bones: Canned sardines, anchovies, and whitebait provide massive amounts of easily absorbed calcium due to the combined presence of phosphorus and vitamin D in the fish.
• Cruciferous vegetables (broccoli, kale, cabbage): The calcium present in these vegetables has a bioavailability rate higher than 50-60% (almost double that of spinach, which is blocked by the high presence of oxalates).
• Sesame seeds (ground or in tahini), almonds and legumes such as chickpeas.
• Unsweetened plant-based drinks enriched with calcium and vitamin D (almond, coconut, oat).

Microbiome health in lactose intolerance

The total and restrictive elimination of any trace of lactose from the diet for a prolonged period without a real clinical indication is a serious strategic error that weakens the intestinal microbiota in the long term.

Dysbiosis associated with blind dairy exclusion

Lactose that is not fully absorbed actually acts as a mild prebiotic in the colon, feeding highly beneficial bacterial populations such as Bifidobacterium and lactobacilli. These beneficial bacteria ferment lactose, producing lactic acid and short-chain fatty acids (acetate, propionate, and butyrate), which acidify the pH of the colon, preventing the growth of opportunistic pathogens such as Escherichia coli either Clostridium.

When lactose is completely eliminated, these prebiotic populations decrease severely (exclusion dysbiosis). If the user accidentally reintroduces dairy in the future, the intolerance symptoms will be ten times more severe due to the loss of adaptation of their gut microbiota.

The role of prebiotics and short-chain fatty acids

To counteract and better tolerate residual lactose, Oorenji's personalized nutritional plan prioritizes soluble prebiotics rich in fructooligosaccharides (FOS) and inulin (found in garlic, onions, leeks, unripe bananas, and chicory). These compounds promote the growth of colonizing bacteria capable of digesting lactose anaerobically and silently (fermentation that does not produce hydrogen or methane gas), significantly improving the tolerance threshold of patients with the CC genotype.

Oorenji: Personalized Nutrition and Digestive Control

At Oorenji (https://oorenji.com), we approach your digestive well-being with molecular precision. Through our advanced genetic test, we accurately identify whether your lactose intolerance is primary (CC genotype) or if your digestive discomfort has a secondary and reversible origin linked to imbalances in your gut microbiota or intestinal barrier.

Our platform translates these biological results directly into:

1. Dietary plans adapted to individual thresholds: Designing menus free of symptomatic lactose but rich in beneficial fermented foods that are highly tolerated to keep your bifidobacteria healthy and active.
2. Nutrient density guarantee: Ensuring that each nutritional plan provides 100% of the calcium and vitamin D requirements adapted to your biological profile, monitoring your clinical evolution.
3. Tools for the nutrition professional (Caloo Pro): Providing your dietitian with a dashboard to monitor your progress, adjust your guidelines, and actively modulate your digestive tolerance with the best available evidence.

Conclusion: Adapt your diet to your biological map

Knowing you have the risk variant in the LCT gene doesn't mean giving up enjoying food or subjecting yourself to severe restrictions. It means gaining the molecular knowledge to make better choices. Adapting your habits to your biological map with Oorenji allows you to make precise decisions to restore your gut health, protect your skeletal system, and intelligently nourish your gut microbiota.

Don't follow restrictive, generic diets based on fear. Take control of your digestive health guided by the strength of your genetics at https://oorenji.com.

Scientific references

• Enattah, NS, Sahi, T., Savilahti, E., Terwilliger, JD, … & Peltonen, L. (2002). Identification of a variant associated with active lactase persistence. Nature Genetics, 30(2), 233-237.
• Swallow, D. M. (2003). Genetics of lactase persistence and lactose intolerance. Annual Review of Genetics, 37(1), 197-219.
• Sahi, T. (1994). Genetics and epidemiology of adult-type hypolactasia. Scandinavian Journal of Gastroenterology, 29(sup202), 7-20.
• Palou, A., & Palou, M. (2021). Nutrigenomics and nutrigenetics: the clinical translation of precision nutrition. Journal of Clinical Medicine, 10(12), 2611.
• Hertzler, S. R., & Savaiano, D. A. (1996). Colonic adaptation to daily lactose feeding in lactose-malabsorbing humans. American Journal of Clinical Nutrition, 63(2), 233-238.